The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Norovirus Vaccine Against Experimental Human GII.4 Virus Illness: A Challenge Study in Healthy Adults
Open accessAbstract
BACKGROUND: Vaccines against norovirus, the leading cause of acute gastroenteritis, should protect against medically significant illness and reduce transmission. METHODS: In this randomized, double-blind, placebo-controlled trial, 18- to 50-year-olds received 2 injections of placebo or norovirus GI.1/GII.4 bivalent vaccine-like particle (VLP) vaccine with 3-O-desacyl-4'-monophosphoryl lipid A (MPL) and alum. Participants were challenged as inpatients with GII.4 virus (4400 reverse transcription polymerase chain reaction [RT-PCR] units), and monitored for illness and infection. RESULTS: Per protocol, 27 of 50 (54.0%) vaccinees and 30 of 48 (62.5%) controls were infected. Using predefined illness and infection definitions, vaccination did not meet the primary endpoint, but self-reported cases of severe (0% vaccinees vs. 8.3% controls; P = .054), moderate or greater (6.0% vs. 18.8%; P = .068), and mild or greater severity of vomiting and/or diarrhea (20.0% vs. 37.5%; P = .074) were less frequent. Vaccination also reduced the modified Vesikari score from 7.3 to 4.5 (P = .002). Difficulties encountered were low norovirus disease rate, and inability to define illness by quantitative RT-PCR or further antibody rise in vaccinees due to high vaccine-induced titers. By day 10, 11 of 49 (22.4%) vaccinees were shedding virus compared with 17 of 47 (36.2%) placebo recipients (P = .179). CONCLUSIONS: Bivalent norovirus VLP vaccine reduced norovirus-related vomiting and/or diarrhea; field efficacy studies are planned. Clinical Trials Registration. NCT01609257.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foodborne illness acquired in the United States—Major pathogens
Scallan, E., Hoekstra, R. M., Angulo, F. J., Tauxe, R. V., Widdowson, M.-A., Roy, S. L., Jones, J. L., & Griffin, P. M. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1701.p11101 · Cited by 7,657
Glass, R. I., Parashar, U. D., & Estes, M. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804575 · Cited by 1,010
Self-citationNorovirus and Medically Attended Gastroenteritis in U.S. Children
Payne, D. C., Vinjé, J., Szilagyi, P. G., Edwards, K. M., Staat, M. A., Weinberg, G. A., Hall, C. B., Chappell, J., Bernstein, D. I., Curns, A. T., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1206589 · Cited by 610
Self-citationMarionneau, S., Ruvoën, N., Le Moullac–Vaidye, B., Clement, M., Cailleau–Thomas, A., Ruiz–Palacois, G., Huang, P., Jiang, X., & Le Pendu, J. (2002) · Gastroenterology · doi:10.1053/gast.2002.33661 · Cited by 526
Self-citationNorovirus Vaccine against Experimental Human Norwalk Virus Illness
Atmar, R. L., Bernstein, D. I., Harro, C. D., Al-Ibrahim, M. S., Chen, W. H., Ferreira, J., Estes, M. K., Graham, D. Y., Opekun, A. R., Richardson, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1101245 · Cited by 490
Self-citationHuang, P., Farkas, T., Marionneau, S., Zhong, W., Ruvoën‐Clouet, N., Morrow, A. L., Altaye, M., Pickering, L. K., Newburg, D. S., LePendu, J., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/375742 · Cited by 415
Self-citationImmunogenetic Mechanisms Driving Norovirus GII.4 Antigenic Variation
Lindesmith, L. C., Beltramello, M., Donaldson, E. F., Corti, D., Swanstrom, J., Debbink, K., Lanzavecchia, A., & Baric, R. S. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002705 · Cited by 266
Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers
Tacket, C. O., Sztein, M. B., Losonsky, G. A., Wasserman, S. S., & Estes, M. K. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00120-7 · Cited by 238
Self-citationRecombinant Norwalk virus–like particles given orally to volunteers: Phase I study
Ball, J. M., Graham, D. Y., Opekun, A. R., Gilger, M. A., Guerrero, R. A., & Estes, M. K. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70548-2 · Cited by 227
Self-citationEl‐Kamary, S. S., Pasetti, M. F., Mendelman, P. M., Frey, S. E., Bernstein, D. I., Treanor, J. J., Ferreira, J., Chen, W. H., Sublett, R., Richardson, C., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/657087 · Cited by 226
Self-citation
Cited by
Robilotti, E., Deresinski, S., & Pinsky, B. A. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00075-14 · Cited by 589
Human norovirus transmission and evolution in a changing world
de Graaf, M., van Beek, J., & Koopmans, M. P. G. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.48 · Cited by 479
The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control
Lopman, B. A., Steele, D., Kirkwood, C. D., & Parashar, U. D. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1001999 · Cited by 457
Bányai, K., Estes, M. K., Martella, V., & Parashar, U. D. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31128-0 · Cited by 445
Self-citationStatic and Evolving Norovirus Genotypes: Implications for Epidemiology and Immunity
Parra, G. I., Squires, R. B., Karangwa, C. K., Johnson, J. A., Lepore, C. J., Sosnovtsev, S. V., & Green, K. Y. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006136 · Cited by 274
Metadata
- Authors
- Bernstein, D. I., Atmar, R. L., Lyon, G. M., Treanor, J. J., Chen, W. H., Jiang, X., Vinje, J., Gregoricus, N., Frenck, R. W., Moe, C. L., Al-Ibrahim, M. S., Barrett, J., Ferreira, J., Estes, M. K., Graham, D. Y., Goodwin, R., Borkowski, A., Clemens, R., & Mendelman, P. M.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-09-09
- Volume
- 211
- Issue
- 6
- Pages
- 870-878
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2115655922
- Cited by
- 276
- References
- 20
- FWCI
- 21.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Norovirus Vaccine Against Experimental Human GII.4 Virus Illness: A Challenge Study in Healthy Adults. https://app.cochat.ai/papers/10.1093/infdis/jiu497
- The paper
- Bernstein, D. I., Atmar, R. L., Lyon, G. M., Treanor, J. J., Chen, W. H., Jiang, X., Vinje, J., Gregoricus, N., Frenck, R. W., Moe, C. L., Al-Ibrahim, M. S., Barrett, J., Ferreira, J., Estes, M. K., Graham, D. Y., Goodwin, R., Borkowski, A., Clemens, R., & Mendelman, P. M. (2015). Norovirus Vaccine Against Experimental Human GII.4 Virus Illness: A Challenge Study in Healthy Adults. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiu497
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.